Citadel Advisors
ARMP icon

Citadel Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Citadel Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$438 – 12438
2025
Q1 		$438 Buy
+300
New +$598 ﹤0.01% 14261
2024
Q4 		– Sell
-400
Closed -$948 – 14459
2024
Q3 		$948 Buy
400
+300
+300% +$767 ﹤0.01% 13930
2024
Q2 		$275 Sell
100
-100
-50% -$285 ﹤0.01% 14045
2024
Q1 		$836 Buy
+200
New +$724 ﹤0.01% 14236

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's ARMP Position: Q1 2026 in Review

Citadel Advisors sold out of Armata Pharmaceuticals (ARMP) in Q1 2026, closing a stake of 10,786 shares — an estimated $67.7K sold.

Citadel Advisors first reported a position in ARMP in Q2 2016 and held it in 15 quarters. The position peaked at $102K in Q1 2021. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Citadel Advisors reported no remaining Armata Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 10,786 Armata Pharmaceuticals shares in Q1 2026, an estimated $67.7K.
  • Citadel Advisors first reported a position in Armata Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • Citadel Advisors's Armata Pharmaceuticals position peaked at $102K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.